GLENVIEW CAPITAL MANAGEMENT, LLC
Q1 2014 13F-HR Holdings
Net value change ($000)
+1,303,688
(9.3%)
New positions
16
Sold out positions
12
Turnover %
23.2%
Sector allocation + QoQ delta (equities-only)
Snapshot: Change Analysis
Compared to Q4 2013
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| WELLPOINT INC | 421,291 | NEW |
| HRI | 353,339 | NEW |
| EBAY | 297,958 | NEW |
| AETNA INC NEW | 277,784 | 223.1% |
| Monsanto | 258,416 | 44.6% |
| HUM | 233,694 | 67.8% |
| AMAT | 225,363 | NEW |
| TMO | 199,219 | 21.0% |
| DG | 184,170 | 103.6% |
| FOSL | 171,301 | 172.0% |
Top Reduces (Value $000, Stocks/ETFs)
| HEALTH MGMT | -494,624 | -100.0% |
| LIFE TECHNOLOGIES | -208,435 | -100.0% |
| Pentair Inc | -188,409 | -62.2% |
| URS CORP NEW COM | -128,163 | -84.5% |
| AAP | -120,712 | -47.1% |
| XEROX CORP | -113,644 | -100.0% |
| MSFT | -94,868 | -48.2% |
| Paramount Global | -92,108 | -32.5% |
| GM | -89,098 | -34.4% |
| CALPINE CORP | -86,370 | -100.0% |
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000):
125,156
(0.8% of total reported value)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|